The Relationship between Depression, Doing Exercise, Age and Cigarettes Smoking in ARV - HIV Patients
Abstract
Introduction: HIV/AIDS has negative effects on the patient's mental health and social interaction, in addition to its negative effects on their physical health. Depression disorder is considered the second mental disorder in the world among patients with HIV/AIDS affects their life and causes social stigma. In Vietnam, various studies on HIV patients and depression disorders were examined. However, there are also many limitations in research with many aspects relate to the mental health quality in HIV patients. This cross-sectional study was conducted to examine the relationship between depression, smoking cigarettes, exercise habits and age in ARV - HIV patients.
Methods: A qualitative approach was utilised to conduct the randomised investigation. The PHQ - 9 scale was used for evaluating depression in 128 Vietnamese ARV - HIV patients participating in the study.
Results: According to the findings, depression and exercise have been shown to have a positive effect on smoking among HIV patients, and geriatric HIV patients are significantly less likely to smoke.
Conclusion: HIV-positive individuals require an accurate identification and assessment of depressive symptoms, with the potential implementation of personalized exercise intensity programs aimed at assisting HIV patients in ceasing tobacco use. In addition, the study recommended exercise planning and patient adherence surveillance as means for assessing and modifying the treatment of HIV patients.
References
Feuillet P, Lert F, Tron L, Aubriere C, Spire B, Dray?Spira R, et al. Prevalence of and factors associated with depression among people living with HIV in France. HIV Medicine. 2017;18(6):383-94.
Campos LN, Guimarães MDC, Remien RH. Anxiety and depression symptoms as risk factors for non-adherence to antiretroviral therapy in Brazil. AIDS Behavior. 2010;14:289-99.
Wang T, Fu H, Kaminga AC, Li Z, Guo G, Chen L, et al. Prevalence of depression or depressive symptoms among people living with HIV/AIDS in China: a systematic review and meta-analysis. BMC Psychiatry. 2018;18(1):1-14.
Alderete-Aguilar C, Cruz-Maycott R, Iglesias MC, Rodríguez-Estrada E, Reyes-Terán G. Assessment of depression, anxiety, hopelessness and suicidal risk in HIV+ inpatients. Salud Mental. 2017;40(1):23-7.
Vega-Ramirez H, Rodriguez V, Cruz J. P021: impulsivity and depressive symptoms in people with HIV diagnosed with a common mental disorder from an HIV clinic in Mexico City. J Int AIDS Soc. 2015;18(3).
Antoni MH, Baggett L, Ironson G, LaPerriere A, August S, Klimas N, et al. Cognitive-behavioral stress management intervention buffers distress responses and immunologic changes following notification of HIV-1 seropositivity. Journal of Consulting Clinical Psychology. 1991;59(6):906.
Ciesla JA, Roberts JEJAjop. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. American Journal of Psychiatry. 2001;158(5):725-30.
Watkins CC, Treisman GJ. Neuropsychiatric complications of aging with HIV. Journal of Neurovirology. 2012;18:277-90.
L’akoa RM, Noubiap JJN, Fang Y, Ntone FE, Kuaban C. Prevalence and correlates of depressive symptoms in HIV-positive patients: a cross-sectional study among newly diagnosed patients in Yaoundé, Cameroon. BMC Psychiatry. 2013;13(1):1-7.
American Psychiatric Association. Mood disorders. Diagnostic and statistical Manual of Mental Disorder 4 th edition. US: American Psychiatric Association; 2000. 168-208 p.
Stek M, Exel Ev, Tilburg Wv, Westendorp R, Beekman A. The prognosis of depression in old age: outcome six to eight years after clinical treatment. Aging Mental Health. 2002;6(3):282-5.
Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine. 2000;133(1):21-30.
Mayston R, Kinyanda E, Chishinga N, Prince M, Patel V. Mental disorder and the outcome of HIV/AIDS in low-income and middle-income countries: a systematic review. Aids. 2012;26:S117-S35.
Meziou O, Ghali F, Hamdi G, Khelifa E, Zalila H. Depression among patients affected by the human immunodeficiency virus. Medecine Et Maladies Infectieuses. 2018;48(5):373-4.
Meade CS, Sikkema KJ. HIV risk behavior among adults with severe mental illness: a systematic review. Clinical Psychology Review. 2005;25(4):433-57.
Schuster R, Bornovalova M, Hunt E. The influence of depression on the progression of HIV: direct and indirect effects. Behavior Modification. 2012;36(2):123-45.
Cruess DG, Evans DL, Repetto MJ, Gettes D, Douglas SD, Petitto JM. Prevalence, diagnosis, and pharmacological treatment of mood disorders in HIV disease. Biological Psychiatry. 2003;54(3):307-16.
Nakimuli?Mpungu E, Musisi S, Smith CM, Von Isenburg M, Akimana B, Shakarishvili A, et al. Mental health interventions for persons living with HIV in low?and middle?income countries: a systematic review. Journal of the International AIDS Society. 2021;24:100-14.
Simoni JM, Safren SA, Manhart LE, Lyda K, Grossman CI, Rao D, et al. Challenges in addressing depression in HIV research: assessment, cultural context, and methods. AIDS Behavior Modification. 2011;15:376-88.
Shuter J, Bernstein SL, Moadel AB. Cigarette smoking behaviors and beliefs in persons living with HIV/AIDS. American Journal of Health Behavior. 2012;36(1):75-85.
Alciati A, Gallo L, Monforte ADA, Brambilla F, Mellado C. Major depression?related immunological changes and combination antiretroviral therapy in HIV?seropositive patients. Human Psychopharmacology: Clinical Experimental. 2007;22(1):33-40.
Carrico AW, Bangsberg DR, Weiser SD, Chartier M, Dilworth SE, Riley ED. Psychiatric correlates of HAART utilization and viral load among HIV-positive impoverished persons. AIDS. 2011;25(8):1113.
Coleman SM, Blashill AJ, Gandhi RT, Safren SA, Freudenreich O. Impact of integrated and measurement-based depression care: clinical experience in an HIV clinic. Psychosomatics. 2012;53(1):51-7.
Betancur MN, Lins L, Oliveira IRd, Brites C. Quality of life, anxiety and depression in patients with HIV/AIDS who present poor adherence to antiretroviral therapy: a cross-sectional study in Salvador, Brazil. Brazilian Journal of Infectious Diseases. 2017;21:507-14.
Abadiga M. Depression and its associated factors among HIV/AIDS patients attending ART clinics at Gimbi General hospital, West Ethiopia, 2018. BMC Research Notes. 2019;12(1):1-8.
Camara A, Sow M, Touré A, Sako F, Camara I, Soumaoro K, et al. Anxiety and depression among HIV patients of the infectious disease department of Conakry University Hospital in 2018. Epidemiology & Infection. 2020;148:e8.
Burkhalter JE, Springer CM, Chhabra R, Ostroff JS, Rapkin BDJN. Tobacco use and readiness to quit smoking in low-income HIV-infected persons. Nicotine Tobacco Research. 2005;7(4):511-22.
Webb MS, Vanable PA, Carey MP, Blair DC. Cigarette smoking among HIV+ men and women: examining health, substance use, and psychosocial correlates across the smoking spectrum. Journal of Behavioral Medicine. 2007;30:371-83.
Humfleet GL, Delucchi K, Kelley K, Hall SM, Dilley J, Harrison G. Characteristics of HIV-positive cigarette smokers: a sample of smokers facing multiple challenges. AIDS Education Prevention. 2009;21(3_supplement):54-64.
Asfar T, Perez A, Shipman P, Carrico AW, Lee DJ, Alcaide ML, et al. National estimates of prevalence, time-trend, and correlates of smoking in US people living with HIV (NHANES 1999–2016). Nicotine Tobacco Research. 2021;23(8):1308-17.
Arcavi L, Benowitz NL. Cigarette smoking and infection. Archives of Internal Medicine. 2004;164(20):2206-
Vidrine DJ, Arduino RC, Gritz ER. Impact of a cell phone intervention on mediating mechanisms of smoking cessation in individuals living with HIV/AIDS. Nicotine Tobacco Research. 2006;8(Suppl_1):S103-S8.
Stewart DW, Jones GN, Minor KS. Smoking, depression, and gender in low-income African Americans with HIV/AIDS. Behavioral Medicine. 2011;37(3):77-80.
Smith TC, LeardMann CA, Smith B, Jacobson IG, Miller SC, Wells TS, et al. Longitudinal assessment of mental disorders, smoking, and hazardous drinking among a population-based cohort of US service members. Journal of Addiction Medicine. 2014;8(4):271-81.
Lee RB, Maria MS, Estanislao S, Rodriguez C. Factors associated with depressive symptoms among Filipino university students. PloS One. 2013;8(11):e79825.
Webb MS, Vanable PA, Carey MP, Blair DC. Medication adherence in HIV-infected smokers: the mediating role of depressive symptoms. AIDS Education Prevention. 2009;21(3_supplement):94-105.
Leventhal AM, Zvolensky MJ. Anxiety, depression, and cigarette smoking: A transdiagnostic vulnerability framework to understanding emotion–smoking comorbidity. Psychological Bulletin. 2015;141(1):176.
Agterberg S, Weinberger AH, Stanton CA, Shuter J. Perceived racial/ethnic discrimination and cigarette smoking behaviors among a sample of people with HIV. Journal of Behavioral Medicine. 2023:1-11.
Rawson RA, Chudzynski J, Mooney L, Gonzales R, Ang A, Dickerson D, et al. Impact of an exercise intervention on methamphetamine use outcomes post-residential treatment care. Drug Alcohol Dependence. 2015;156:21-8.
Yahiaoui A, McGough EL, Voss JG. Development of evidence-based exercise recommendations for older HIV-infected patients. Journal of the Association of Nurses in AIDS Care. 2012;23(3):204-19.
Blake HJBjocn. Innovation in practice: mobile phone technology in patient care. British Journal of Community Nursing. 2008;13(4):160-5.
McDonald D, O'Brien J, Farr E, Haaga DA. Pilot study of inducing smoking cessation attempts by activating a sense of looming vulnerability. Addictive Behaviors. 2010;35(6):599-606.
Thai TT, Jones MK, Harris LM, Heard RC, Hills NK, Lindan CP. Symptoms of depression in people living with HIV in Ho Chi Minh City, Vietnam: prevalence and associated factors. AIDS Behavior Modification. 2018;22:76-84.
Tran BX, Dang AK, Truong NT, Ha GH, Nguyen HLT, Do HN, et al. Depression and quality of life among patients living with HIV/AIDS in the era of universal treatment access in Vietnam. International Journal of Environmental Research Public Health. 2018;15(12):2888.
Dillman DA. Mail and Internet surveys: The tailored design method--2007 Update with new Internet, visual, and mixed-mode guide. Canada John Wiley & Sons.; 2011.
Kroenke K, Spitzer RL, Williams JB. The PHQ?9: validity of a brief depression severity measure. Journal of General Internal Medicine. 2001;16(9):606-13.
Do PH, Vo VT, Luong-Thanh B-Y, Nguyen LH, Valdebenito S, Eisner M, et al. 728 Comparative performance of WHO-5, PHQ-9 and PSS Scale for screening antenatal depression and suicide risk. International Journal of Epidemiology. 2021;50(Supplement_1):dyab168-6.
Hair JF, Risher JJ, Sarstedt M, Ringle CM. When to use and how to report the results of PLS-SEM. European Business Review. 2019;31(1):2-24.
Hair Jr JF, Hult GTM, Ringle CM, Sarstedt M, Danks NP, Ray S. Partial least squares structural equation modeling (PLS-SEM) using R: A workbook: Springer Nature; 2021.
McKight PE, Najab J. Kruskal?wallis test. The corsini Encyclopedia of Psychology. 2010:1-.
Hair JF, Ringle CM, Sarstedt M. PLS-SEM: Indeed a silver bullet. Journal of Marketing Theory and Practice. 2011;19(2):139-52.
Chin WW, Marcolin BL, Newsted PR. A partial least squares latent variable modeling approach for measuring interaction effects: Results from a Monte Carlo simulation study and an electronic-mail emotion/adoption study. Information Systems Research. 2003;14(2):189-217.
Khan GF, Sarstedt M, Shiau W-L, Hair JF, Ringle CM, Fritze MP. Methodological research on partial least squares structural equation modeling (PLS-SEM) An analysis based on social network approaches. Internet Research. 2019;29(3):407-29.
Lilliefors HW. On the Kolmogorov-Smirnov test for normality with mean and variance unknown. Journal of the American Statistical Association. 1967;62(318):399-402.
Falk RF, Miller NB. A primer for soft modeling. Ohio: University of Akron Press; 1992.
Cohen J. Statistical power analysis for the behavioral sciences. US: Academic press; 2013.
Arseniou S, Arvaniti A, Samakouri M. HIV infection and depression. Psychiatry and Clinical Neurosciences. 2014;68(2):96-109.
Nanni MG, Caruso R, Mitchell AJ, Meggiolaro E, Grassi L. Depression in HIV infected patients: a review. Current Psychiatry Reports. 2015;17:1-11.
Del Guerra F, Fonseca J, Figueiredo V, Ziff E, Konkiewitz EC. Human immunodeficiency virus-associated depression: contributions of immuno-inflammatory, monoaminergic, neurodegenerative, and neurotrophic pathways. Journal of Neurovirology. 2013;19:314-27.
Shuter J, Bernstein SL. Cigarette smoking is an independent predictor of nonadherence in HIV-infected individuals receiving highly active antiretroviral therapy. Nicotine & Tobacco Research. 2008;10(4):731-6.
Rubin LH, Maki PM. HIV, depression, and cognitive impairment in the era of effective antiretroviral therapy. Current HIV/aids Reports. 2019;16:82-95.
Hader SL, Smith DK, Moore JS, Holmberg SD. HIV infection in women in the United States: status at the millennium. Jama. 2001;285(9):1186-92.
Reis RK, Haas VJ, Santos CBd, Teles SA, Galvão MTG, Gir E. Symptoms of depression and quality of life of people living with HIV/AIDS. Revista Latino-americana de Enfermagem. 2011;19:874-81.
Bromet E, Andrade LH, Hwang I, Sampson NA, Alonso J, De Girolamo G, et al. Cross-national epidemiology of DSM-IV major depressive episode. BMC Medicine. 2011;9(1):1-16.
Piccinelli M, Wilkinson G. Gender differences in depression: Critical review. The British Journal of Psychiatry. 2000;177(6):486-92.
Lyubomirsky S, Layous K, Chancellor J, Nelson SK. Thinking about rumination: The scholarly contributions and intellectual legacy of Susan Nolen-Hoeksema. Annual Review of Clinical Psychology. 2015;11:1-22.
Sulaiman T, Hassan A, Sapian VM, Abdullah SK. The level of stress among students in urban and rural secondary schools in Malaysia. European Journal of Social Sciences. 2009;10(2):179-84.
Brody DJ, Pratt LA, Hughes JP. Prevalence of depression among adults aged 20 and over: United States, 2013-2016. National Center for Health Statistics. 2018(303).
Adeoti AO, Dada MU, Fadare JO. Prevalence of depression and anxiety disorders in people living with HIV/AIDS in a tertiary hospital in South Western Nigeria. Medical Reports & Case Studies. 2018;3(1):1-5.
Ghidei L, Simone MJ, Salow MJ, Zimmerman KM, Paquin AM, Skarf LM, et al. Aging, antiretrovirals, and adherence: a meta analysis of adherence among older HIV-infected individuals. Drugs & Aging. 2013;30:809-19.
Weinberger AH, Gbedemah M, Martinez AM, Nash D, Galea S, Goodwin RD. Trends in depression prevalence in the USA from 2005 to 2015: widening disparities in vulnerable groups. Psychological Medicine. 2018;48(8):1308-15.
Othieno CJ, Okoth R, Peltzer K, Pengpid S, Malla LO. Risky HIV sexual behaviour and depression among University of Nairobi students. Annals of General Psychiatry. 2015;14:1-8.
Hogarth L, Mathew AR, Hitsman B. Current major depression is associated with greater sensitivity to the motivational effect of both negative mood induction and abstinence on tobacco-seeking behavior. Drug and Alcohol Dependence. 2017;176:1-6.
Mykletun A, Overland S, Aarø LE, Liabø H-M, Stewart R. Smoking in relation to anxiety and depression: evidence from a large population survey: the HUNT study. European Psychiatry. 2008;23(2):77-84.
Bénard A, Bonnet F, Tessier J-F, Fossoux H, Dupon M, Mercié P, et al. Tobacco addiction and HIV infection: toward the implementation of cessation programs. ANRS CO3 Aquitaine Cohort. AIDS Patient Care and STDs. 2007;21(7):458-68.
Kowal J, Overduin LY, Balfour L, Tasca GA, Corace K, Cameron DW. The role of psychological and behavioral variables in quality of life and the experience of bodily pain among persons living with HIV. Journal of Pain and Symptom Management. 2008;36(3):247-58.
Luo X, Duan S, Duan Q, Pu Y, Yang Y, Ding Y, et al. Tobacco use among HIV-infected individuals in a rural community in Yunnan Province, China. Drug and Alcohol Dependence. 2014;134:144-50.
Encrenaz G, Bénard A, Rondeau V, Bonnet F, Lazaro E, Neau D, et al. Determinants of smoking cessation attempts among HIV-infected patients: results from a hospital-based prospective cohort. Current HIV Research. 2010;8(3):212-7.
Jackson-Morris A, Fujiwara P, Pevzner E. Clearing the smoke around the TB-HIV syndemic: smoking as a critical issue for TB and HIV treatment and care. The International Journal of Tuberculosis and Lung Disease. 2015;19(9):1003-6.
Ghura S, Gross R, Jordan-Sciutto K, Dubroff J, Schnoll R, Collman RG, et al. Bidirectional associations among nicotine and tobacco smoke, neuroHIV, and antiretroviral therapy. Journal of Neuroimmune Pharmacology. 2020;15:694-714.
Marks King R, Vidrine DJ, Danysh HE, Fletcher FE, McCurdy S, Arduino RC, et al. Factors associated with nonadherence to antiretroviral therapy in HIV-positive smokers. AIDS Patient Care and STDs. 2012;26(8):479-85.
Ussher MH, Taylor AH, Faulkner GE. Exercise interventions for smoking cessation. Cochrane Database of Systematic Reviews. 2014(8).
Abrantes AM, Blevins CE. Exercise in the context of substance use treatment: key issues and future directions. Current Opinion in Psychology. 2019;30:103-8.
Wang D, Wang Y, Wang Y, Li R, Zhou C. Impact of physical exercise on substance use disorders: a meta-analysis. PloS One. 2014;9(10):e110728.
Katomeri M, Taylor A, editors. Effects of walking on desire to smoke and withdrawal symptoms during a smoking cue, and ad libitum smoking. European College of Sports Science Annual Conference Book of Abstracts Lausanne, Switzerland: European College of Sports Science; 2006.
Swalve N, Smethells JR, Younk R, Mitchell J, Dougen B, Carroll ME. Sex-specific attenuation of impulsive action by progesterone in a go/no-go task for cocaine in rats. Psychopharmacology. 2018;235:135-43.
Benton TDJCPR. Depression and hiv/aids. Current Psychiatry Reports. 2008;10(3):280-5.
Bradley MV, Remien RH, Dolezal C. Depression symptoms and sexual HIV risk behavior among serodiscordant couples. Psychosomatic Medicine. 2008;70(2):186-91.
Authors who publish with Journal of Public Health and Pharmacy retain the copyright of their work. The journal applies a Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA 4.0), which grants the following rights:
-
Copyright Retention: Authors retain the copyright of their work, maintaining full control over their intellectual property without restrictions.
-
Right of First Publication: Authors grant the journal the right of first publication of their work. This ensures that the work is initially published and credited in Journal of Public Health and Pharmacy.
-
License to Share and Reuse: The work is licensed under CC BY-SA 4.0, allowing others to copy, distribute, remix, and build upon the work for any purpose, even commercially, as long as proper credit is given to the authors, and any new creations are licensed under the same terms.
